Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
General anesthesia, in the context of the Peking University First Hospital clinical trial (NCT01640262), refers to a standard anesthetic regimen used as a comparator against combined epidural-general anesthesia in elderly patients undergoing surgery for malignant solid tumors. This specific protocol involves induction with the intravenous anesthetic propofol, maintenance of anesthesia using propofol and/or the volatile inhalational agent sevoflurane, and postoperative pain management via intravenous morphine. The study aims to determine if the choice of anesthetic technique influences long-term oncological outcomes, such as 5-year survival and cancer recurrence, by potentially modulating the perioperative stress response and immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on general anesthesia.